America put me out of business homepage
1354  days in business since  challenge
3057  days dispensing drugs to  the us
Don't let drug companies like Pfizer put me Daren Jorgenson out of business by continuing to cut off supply to our pharmacies around the world if we sell their products to Americans. I want you to put me out of business by forcing these drug companies to sell their products to American Pharmacies at fair and reasonable prices.Daren Jorgenson Bsc PharmI want Americans to put me out of business the right way!
CanadaMeds.comAmerican Drug ClubCanadaRx.com
DAILY NEWS ARTICLES
WEEKLY NEWS ARTICLE
WEEKLY POLITICAL COMMENTS
DAILY POLITICAL NEWS ARTICLES
Political Supporters of Drug re-importation
JOHN KERRY SPEAKS

Click here to view Darens message to the American people.
MICHAEL MOORE COMMENTARIES
Toll Free
1-877-855-6995

Fax
1-877-855-6996
SIGN UP FOR OUR DAILY NEWSLETTER
Is Legalizing the purchase of prescription drugs from Canada the Answer?
 

Governments fuel growth in healthcare IT market

Posted At Reuters.com

BY : Ben Hirschler

By Ben Hirschler, European Pharmaceuticals Correspondent

LONDON (Reuters) - Medicine is an increasingly hi-tech business, but doctors and hospitals around the world remain bogged down in paperwork.

The result can be lost records, clerical errors and mis-prescribing of drugs.

Now, in a bid to improve patient care, governments in Europe and North America are pushing for the adoption of electronic records and data transfers, which is kick-starting the growth of a hybrid business that attracts companies from both the healthcare and tech arenas.

Worldwide, the healthcare information technology market is estimated to be worth more than $50 billion a year, and industry executives -- lining up for a slice of the action -- told a conference this week its growth would be in double digits for the foreseeable future.

The sector has become a lure for industrial giants such as General Electric Co. (GE.N: Quote, Profile, Research) and Siemens AG (SIEGn.DE: Quote, Profile, Research), both of which have targeted health as an area for future growth.

Traditionally, IT has been used within healthcare mainly for back-office functions, such as billing and hospital admissions.

The big prize, however, lies in incorporating IT into patient treatment via a process known as "clinical decision support" that can guide physicians through their options.

"We have a long way to go in healthcare. We are bound by paper, and paper is not working," Mark Dente, director of GE's Healthcare Solutions division, told the Kepler Equities conference.

GE, like its German rival Siemens, reckons it can become a major player in this business by combining its IT skills with its existing capability in making medical monitoring equipment.

The healthcare IT business currently is fragmented and represented by a large number of often regional players.

But consolidation is picking up.

GE made a splash in September by agreeing to buy IDX Systems Corp. (IDXC.O: Quote, Profile, Research), a maker of software used to track patient records, for $1.2 billion in a move to help it compete with rivals such as Cerner Corp. (CERN.O: Quote, Profile, Research) and McKesson Corp. (MCK.N: Quote, Profile, Research).

In Europe, meanwhile, Belgium's Agfa Gevaert (AGFAt.BR: Quote, Profile, Research) has struck a number of deals to secure its position in digital picture archiving and communications as hospitals move away from traditional medical film products.

UNDERSERVED AT PRESENT

Spending on IT currently accounts for just 2.2 percent of sales in healthcare, against 3.9 percent in retail and 11.1 percent in financial services, according to consultancy INPUT.

In part, that may reflect the complexity of a medical diagnosis.

But cheaper computing power is starting to change the attitude toward spending on IT, and governments -- including those of the United States, Canada, Germany and Britain -- are putting in place specific healthcare policies that are expected to accelerate demand for IT services.

"Without the government pushing, a lot of this work wouldn't be getting done," Dente said.

In the United States, where a bill to encourage IT development cleared the Senate's Health, Education, Labor and Pensions Committee in July, a recent study predicted that computerized medical records could save $81 billion a year.

Roche Holding AG (ROG.VX: Quote, Profile, Research), the world leader in diagnostics, believes it also stands to gain from the growing demand for more sophisticated health information.

"Governments and payers are increasingly asking for better ways to decrease medical errors and increase accuracy," said Per-Olof Attinger, general manager of Roche's Instrument Center.

In the past, diagnostic tests produced simple, easily interpreted read-outs, such as blood glucose levels. But the analysis of complex diseases, such as leukemia, produces hundreds of data points, putting a premium on interpretation, he said.


ARTICLES OF THE DAY

Bill to allow pharmacies to reimport drugs passes Senate

The Oklahoma Senate backs a drug reimportation plan that would permit state pharmacies to obtain U-S-made prescription drugs from Canada and elsewhere for sale here.The Federal Drug Administration has opposed drug reimportation bills, claiming they violate the Interstate Commerce Clause of the U-S Constitution. Those measures mainly deal with allowing individuals to obtain reimported drugs. Tulsa state Senator Tom Adelson says his legislation avoids that legal question because it would require pharmacies to sell reimported medicines only to Oklahomans in intrastate, not interstate, commerce. Most programs are geared to allowing individuals obtain such drugs by crossing the border into Canada or buying drugs online.

March 08, 2006

Democrats allege bad deal on drugs

Bay Area seniors are not saving significant money under Medicare's new prescription drug program, according to a report released Monday by most of the Bay Area's House Democrats. The report says Bay Area prices for 2004's 10 best-selling prescription drugs among seniors are 75 percent higher under the new Medicare Part D prescription drug benefit than under deals negotiated by the federal government at other agencies such as the Department of Veterans Affairs. Medicare Part D's prices also are 60 percent higher than those paid by consumers in Canada; almost 5 percent higher than prices on Drugstore.com; and almost 2 percent higher than prices at Costco, the report found. But Republicans who shepherded the bill through Congress rejected a proposal to let Medicare negotiate with drug companies for lower prices. The report proves "what we've been saying since the debate on the Republican Medicare drug bill began," said Rep. Pete Stark, D-Fremont, in a news release. "If you create a privatized drug benefit and refuse to let the government negotiate lower prices, senior citizens and people with disabilities will pay the price," said Stark, who as ranking Democrat on the House Ways and Means Committee's Health Subcommittee is particularly outspoken on the issue. "Instead of attempting to set Medicare on the road to privatization, Republicans in Congress should have worked with Democrats to establish a real prescription benefit within Medicare."

March 08, 2006